News & Updates

The full analysis of the phase III COMMANDS trial continues to demonstrate the superiority of luspatercept over epoetin alfa for the treatment of erythropoiesis-stimulating agent (ESA)-naïve patients with transfusion-dependent lower-risk myelodysplastic syndromes (TD LR-MDS).

A retrospective, 12-year study of approximately 160,000 adult patients admitted to surgical or medical intensive care units (ICUs) in Hong Kong finds dysnatraemia at admission to be associated with higher risks of ICU and in-hospital mortality, underscoring the need for adequate fluid management before ICU stay.

Screening for liver fibrosis appears to spur lifestyle improvements especially among people who screened positive for the condition, according to a study.

A single infusion of lovotibeglogene autotemcel (lovo-cel) resulted in near-complete resolution of vaso-occlusive events (VOEs) among patients with sickle cell disease (SCD), according to the combined analysis of phase I/II HGB-206 group C and phase III HGB-210 studies presented at ASH 2023.

Cervical length as measured by transperineal ultrasound can predict preterm delivery in women with threatened preterm labour, according to results of a retrospective observational study in 60 Hong Kong women.